Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.

Oncotarget · 2015 · PMC4413618 · PMID 25605239

Europe PMC DOI

hedged sentence

0.0479

closest p · 1.0× alpha

0.0479

boldest claim

The sentences

borderline significancep=0.0479actually significant

CXXC5 expression showed a difference of only borderline significance for the pan-PI3K inhibitor GDC0941 (Figure 6 , p=0.0479).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.